Merck: Experimental COVID-19 pill cuts deaths by half

Merck & Co. said that its experimental COVID-19 pill reduced hospitalizations and deaths by half in people recently infected with the coronavirus and that it would soon ask health officials in the U.S. and around the world to authorize its use.